Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®
Clinical trial NCT03357796 · COMPLETED
Trial details
- NCT number
- NCT03357796
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2017-12-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.